Catalyst Wire Dossier Catalyst Wire Dossier

JTT-130

· Akros Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JTT-130, covering 2013-02-04 to 2013-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients [Phase 2]

See pricing